1. Home
  2. SRTA vs SIGA Comparison

SRTA vs SIGA Comparison

Compare SRTA & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

N/A

Current Price

$4.54

Market Cap

472.4M

Sector

N/A

ML Signal

N/A

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

HOLD

Current Price

$5.18

Market Cap

401.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTA
SIGA
Founded
2014
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
472.4M
401.0M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
SRTA
SIGA
Price
$4.54
$5.18
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.63
N/A
AVG Volume (30 Days)
808.8K
475.0K
Earning Date
01-01-0001
06-15-2026
Dividend Yield
N/A
10.97%
EPS Growth
N/A
N/A
EPS
N/A
0.32
Revenue
N/A
N/A
Revenue This Year
$37.89
N/A
Revenue Next Year
$14.33
$132.36
P/E Ratio
$9.88
$17.09
Revenue Growth
N/A
N/A
52 Week Low
$3.85
$4.95
52 Week High
$6.02
$9.62

Technical Indicators

Market Signals
Indicator
SRTA
SIGA
Relative Strength Index (RSI) 46.64 24.50
Support Level $4.26 N/A
Resistance Level $5.46 $6.98
Average True Range (ATR) 0.23 0.26
MACD 0.03 -0.14
Stochastic Oscillator 41.76 2.51

Price Performance

Historical Comparison
SRTA
SIGA

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Share on Social Networks: